Transparency Market Research Report Added "Antibiotics Market" to its database.
Albany, NY -- (SBWIRE) -- 03/25/2015 -- Antibiotics are used to treat diseases caused by pathogens, especially bacteria. Antibiotics work in two ways: they are either used to eradicate bacteria in the body or to impede their development. While antibiotics have been a huge part of the world of medicine and healthcare particularly since the discovery of penicillin in 1928, their importance has grown in recent decades thanks to large-scale innovation and development to protect against the possible side effects of antibiotics. New types of antibiotics have been invented in the past few decades in order to expand the ability of healthcare professionals to combat specific conditions with dedicated antibiotics that cause the least degree of side effects as possible. Growing understanding of the importance of antibiotic research is also expected to help the antibiotics market gain government support in various regions of the world.
Primarily due to the aforementioned factors, the antibiotics market grew at a strong CAGR of 6.6% from 2005 to 2011. It is expected to reach a market value of US$44.68 billion by 2016.
Early buyers will receive 10% customization on reports:
Aminoglycoside Antibodies to Continue Domination of Antibiotics Market
The antibiotics market is divided into various types of antibiotics such as aminoglycoside antibiotics, tetracyclines, penicillin, streptomycin, erythromycin, and chloramphenicol. Of these, aminoglycoside antibodies lead the global antibiotics market with a dominant market share of 79%. Penicillin, erythromycin, tetracyclines, streptomycin, and chloramphenicol are the next most popular product categories in the antibiotics market, with market shares of 8%, 7%, 4%, 1%, and 1%, respectively.
Asia Pacific Antibiotics Market to Show Promising Growth
According to geographical distribution, the antibiotics market is divided into four major regional markets: North America, Europe, Asia Pacific, and Rest of the World. Of these, the Asia Pacific market for antibiotics is expected to show a strong growth in the coming years due to expanding healthcare infrastructure in developing Asian countries such as China, Japan, and South Korea. North America and Europe, the two most technologically advanced, economically developed, and affluent regions in the world, are expected to witness an interesting tussle that could determine the long-term future of the antibiotics industry.
Concerns over Antibiotic Resistance to Hamper Growth of Antibiotics Market
The two prime factors that are expected to influence the development of the global antibiotics market in the near future are:
- Impending expiry of patents currently held by major antibiotics manufacturers
- Growing resistance to the antibiotics market due to potential side effects and antibiotic resistance.
As the major patents on established antibiotic products begin to expire, smaller market players will be at par to compete with established market giants, bringing about revolutionary upheavals in the competitive landscape of the global antibiotics market.
The second factor is a stronger restraint and is already encouraging major market players to increase innovation efforts into developing antibiotics with as few adverse side effects as possible, including anti-MRSA treatment. Since antibiotics, unlike most other types of medicines, are bioactive substances, they can generate cataclysmic reactions from the human body if certain conditions are fulfilled. This opens up a market opportunity for innovation into low-risk antibiotics, but it is expected to hamper the growth of the antibiotics market in the near future.
Major Players in the Antibiotics Market
The global antibiotics market is dominated by companies such as Johnson & Johnson, Bayer HealthCare AG, Astellas Pharma, Inc, Roche, Abbott Laboratories, Bristol-Myers Squibb Co., Middle Brook Pharmaceuticals, Cubist Pharmaceuticals, Inc., Daiichi Sankyo Company, Limited, Takeda Pharmaceutical Company, Ltd., GlaxoSmithKline Plc, Eli Lilly and Co., Kyorin Pharmaceutical Co., Ltd, LG Life Sciences Limited, Inc, Pfizer Inc., Plivad.d., Novartis AG, Sanofi-Aventis SA, and Toyama Chemical Co., Ltd.
The competitive landscape of the global antibiotics market is expected to undergo potentially massive changes regarding the market hierarchy, but major market players are expected to retain their dominant market shares.
More Reports on Pharmaceutical Market :
Enquiry Before Buying :
About Transparency Market Research
TMR's analysts and consultants are distinguished experts in their respective domains. The company is based on an employee-centric model and hires the best, brightest, and most passionate people in the industry. This unparalleled expertise helps TMR uncover latest market intelligence data that's distinct from the competition.
TMR is also a client-centric organization that endeavors to add value to the client's business by delivering the most insightful research. TMR understands that every client has unique product/service offerings, statement, and criteria. Customized solutions from TMR are centered on the client's problem statement. On the other hand, our syndicated research reports provide a packaged solution to keep enterprises abreast of the next major change in their industry.
Transparency Market Research
90 State Street,
NY - 12207
USA - Canada Toll Free 866-552-3453
Browse Market Research Blog: